Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines

被引:8
|
作者
Sams, A
Hastrup, S
Andersen, M
Thim, L
机构
[1] Novo Nordisk AS, Dept Mol Pharmacol, DK-2760 Malov, Denmark
[2] Novo Nordisk AS, Dept Microbial Cell Technol, DK-2760 Malov, Denmark
[3] Novo Nordisk AS, Dept Prot Engn, DK-2760 Malov, Denmark
关键词
GLP-2; receptor; G alpha protein signalling; intestinal growth; RT-PCR; western blot; cAMP;
D O I
10.1016/j.ejphar.2005.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although clinical trials with GLP-2 receptor agonists are currently ongoing, the mechanisms behind GLP-2-induced intestinal epithelial growth remain to be understood. To approach the GLP-2 mechanism of action this study aimed to identify intestinal cell lines endogenously expressing the GLP-2 receptor. Here we report the first identification of a cell line endogenously expressing functional GLP-2 receptors. The human intestinal epithelial cell line, FHC, expressed GLP-2 receptor encoding mRNA (RT-PCR) and GLP-2 receptor protein (Western blot). In cultured FHC cells, GLP-2 induced concentration dependent cAMP accumulation (pEC50=9.7 +/- 0.04 (mean S.E.M., n=4)). In addition, a naturally occurring human intestinal fibroblast cell line, 18Co, endogenously expressing GLP-2 receptor encoding mRNA (RTPCR) and protein (Western blot) was identified. No receptor functionality (binding or G-protein signalling) could be demonstrated in 18Co cells. The identified gut-relevant cell lines provide tools for future clarification of the mechanisms underlying GLP-2-induced epithelial growth. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [1] Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2)
    Hartmann, B
    Johnsen, AH
    Orskov, C
    Holst, JJ
    DIABETES, 1996, 45 : 1117 - 1117
  • [2] Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms
    Stahel, Priska
    Xiao, Changting
    Davis, Xenia
    Tso, Patrick
    Lewis, Gary F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (08) : 1565 - 1573
  • [3] Distribution of glucagon-like peptide-2 (GLP-2) in normal colonic tissue
    Caddy, GR
    Johnston, CF
    Ardill, JES
    Pogue, KM
    Collins, JSA
    Gardiner, KR
    Watson, PR
    GASTROENTEROLOGY, 2001, 120 (05) : A683 - A683
  • [4] Evidence for a role for glucagon-like peptide-2 (GLP-2) in ruminant animals
    Taylor-Edwards, Christina
    McLeod, Kyle R.
    Matthews, James C.
    Holst, Jens J.
    Harmon, David L.
    FASEB JOURNAL, 2007, 21 (06): : A1077 - A1077
  • [5] Glucagon-like peptide-2 (GLP-2) modulates intestinal permeability in the parenterally fed neonatal gut
    Kansagra, K
    Stoll, B
    Rognerud, C
    Ou, CN
    Burrin, D
    PEDIATRIC RESEARCH, 2003, 53 (04) : 395A - 395A
  • [6] Glucagon-like peptide-2 (GLP-2) modulates intestinal permeability in the parenterally fed neonatal gut
    Kansagra, K
    Stoll, B
    Lu, XF
    Rognerud, C
    Ou, CN
    Burrin, D
    FASEB JOURNAL, 2003, 17 (04): : A305 - A305
  • [7] Signal transduction pathways in glucagon-like peptide-2 (GLP-2) induced intestinal epithelial cell proliferation.
    Jasleen, J
    Shen, R
    Tavakkolizadeh, A
    Whang, E
    Jacobs, D
    Zinner, M
    Ashley, SW
    GASTROENTEROLOGY, 1999, 116 (04) : A892 - A892
  • [8] Glucagon-like peptide-2 (GLP-2) increases mesenteric blood flow in humans
    Bremholm, Lasse
    Hornum, Mads
    Henriksen, Birthe
    Larsen, Steen
    Holst, Jens J.
    GASTROENTEROLOGY, 2007, 132 (04) : A241 - A241
  • [9] The Combination of Dietary Lipids and a Sweetener Creates a Synergy on the Intestinal Glucagon-Like Peptide-2(GLP-2) Secretion
    Sato, Shingo
    Hokari, Ryota
    Hozumi, Hideaki
    Ueda, Toshihide
    Higashiyama, Masaaki
    Okada, Yoshikiyo
    Kurihara, Chie
    Komoto, Shunsuke
    Watanabe, Chikako
    Nakamura, Mitsuyasu
    Tomita, Kengo
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Miura, Soichiro
    GASTROENTEROLOGY, 2011, 140 (05) : S322 - S323
  • [10] Chronic administration of glucagon-like peptide-2 (GLP-2) alters murine intestinal enterocyte form and function
    Benjamin, MA
    Yang, PC
    McKay, DM
    Perdue, M
    GASTROENTEROLOGY, 1999, 116 (04) : A918 - A918